Skip to content
See the World Through ScienceA project of ALLATRA
Source: Peer-reviewedNature Aging1 source

A Blood Test Did as Well as a Spinal Tap at Finding Alzheimer's Plaques

Science

Republish this story

Our work is licensed under Creative Commons BY-NC 4.0. You may republish this piece for free — with credit to ALLATRA Media and a link to the original, unedited beyond length trims, and not for commercial use.

Read the full license

A gloved medical worker slides a needle into a patient's forearm to draw a blood sample.
Both of the blood tests in the study start with a draw like this one (illustrative). The photograph was taken June 19, 2008."USMC-080619-M-8591B-004" by Cpl. Tyler B. Barstow, via Wikimedia Commons, Public domain

Two Alzheimer's blood tests identified brain amyloid about as accurately as the authorized spinal fluid tests they could replace, with every test read at the cutoff values regulators approved. Noëlle Warmenhoven, Sebastian Palmqvist and colleagues at Lund University in Sweden ran the comparison in 129 memory clinic patients, 220 primary care patients and 165 in the North American ADNI study.

The team reports that clinicians able to order either test may have to choose between them, and that no earlier study had compared the two at the cutoffs approved for clinical use. The results were published Nov. 18, 2026, in Nature Aging.

Both tests measure p-tau217, a form of tau protein, on Fujirebio's Lumipulse platform: one alone, one as a ratio to amyloid-beta-42. The Food and Drug Administration has cleared the ratio, read with two cutoffs, for detecting amyloid plaques in patients with cognitive symptoms in specialist care, and p-tau217 alone carries a CE mark in Europe. Judged against amyloid PET brain scans, each blood test classified 83% to 92% of participants correctly, and adding a second cutoff that leaves borderline samples unclassified put p-tau217 at 90% to 97% in the two Swedish groups. None of those differences in accuracy against the spinal fluid tests was statistically significant.

Three panels of receiver operating characteristic curves comparing blood and spinal fluid markers against amyloid PET.
Curves for the memory clinic, primary care and research cohorts, with the areas under them printed beside each marker. Fig. 2 from Noëlle Warmenhoven, Alexa Pichet Binette, Lyduine E. Collij, Shorena Janelidze, Niklas Mattsson-Carlgren, Pontus Tideman, Ruben Smith, Olof Strandberg, Nicholas J. Ashton, Henrik Zetterberg, Alzheimer’s Disease Neuroimaging Initiative, Michael Weiner, Erik Stomrud, Gemma Salvadó, Oskar Hansson, Sebastian Palmqvist (2026), "Comparing plasma p-tau217 and plasma p-tau217/Aβ42 with CSF biomarkers for assessing Alzheimer’s disease pathology", Nature Aging — CC BY 4.0, resized

The differences sat elsewhere — in primary care the ratio test cleared only 62% of people who had no amyloid, against the 91% its manufacturer reports. Under published practice guidelines, the authors write that p-tau217 reached the bar for replacing a scan or a spinal tap in the memory clinic and the lower triage bar in primary care, while both spinal fluid tests reached only the triage bar. They conclude that the blood tests could serve as an alternative to spinal fluid testing in patients with cognitive symptoms.

All the participants had cognitive symptoms, the use the tests are authorized for, and almost all were white. Funding came in part from the U.S. National Institute on Aging; several authors declare fees from drug and diagnostics companies, and one is an employee of both Lund University and the drugmaker Lilly.

Sources

Medical Disclaimer: This content is provided for general informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition, concern, symptom, or treatment decision.

Spot an error?

Spot an error?

Report an error

Spotted a mistake on this page? Tell us what's wrong and our editors will take a look.

What kind of problem?

Only if you'd like us to be able to follow up. We won't use it for anything else.

We correct mistakes openly. Select any text to flag it. Fixes are logged under our Corrections Policy.

Report an error

Reporting on

A Blood Test Did as Well as a Spinal Tap at Finding Alzheimer's Plaques

What kind of problem?

Only if you'd like us to be able to follow up. We won't use it for anything else.

We read every report. Corrections are logged publicly.